MSDS

MATERIAL SAFETY DATA SHEET
SHEETROCK® Topping Joint Compound Ready Mixed
MSDS #61-370-001
Page 1 of 9
61370001
SECTION 1
CHEMICAL PRODUCT AND IDENTIFICATION
United States Gypsum Company
550 West Adams Street
Chicago, Illinois 60661-3637
A Subsidiary of USG Corporation
Product Safety: 1 [phone]
www.usg.com
Version Date: January 1, 2011
Version: 8
PRODUCT(S)
SHEETROCK® Topping Joint Compound Ready Mixed
CHEMICAL FAMILY /
GENERAL CATEGORY
Joint Treatment
SYNONYMS
Joint Compound, Taping Compound, Mud
SECTION 2
HAZARD IDENTIFICATION
EMERGENCY OVERVIEW:
ΔCAUTION!
This product is not expected to produce any unusual hazards during normal use. Exposure to high dust levels may
irritate the skin, eyes, nose, throat, or upper respiratory tract. This product does not present an inhalation, ingestion, or
contact health hazard unless subjected to operations such as sawing, sanding or machining which result in the
generation of airborne particulate. This product contains quartz (crystalline silica) as a naturally occurring
contaminant. Prolonged and repeated breathing of respirable talc and/or mica dust may cause lung disease
(pneumoconiosis).
POTENTIAL HEALTH EFFECTS (See Section 11 for more information)
ACUTE :
Inhalation
Exposure to dust generated during the handling or sanding of the product may cause temporary
irritation to eyes, skin, nose, throat, and upper respiratory tract. Persons subjected to large amounts
of this dust will be forced to leave area because of nuisance conditions such as coughing, sneezing
and nasal irritation. Labored breathing may occur after excessive inhalation. If respiratory symptoms
persist, consult physician.
Eyes
Dust can cause temporary mechanical irritation of eyes. If burning, redness, itching, pain or other
symptoms persist or develop, consult physician.
Skin
None known.
Ingestion
None known.
CHRONIC:
Inhalation
Prolonged and repeated breathing of respirable talc and/or mica dust may cause lung disease
(pneumoconiosis). The extent and severity of lung injury correlates with the length of exposure and
dust concentration.Exposures to respirable crystalline silica are not expected during the normal use of
this product; however, actual levels must be determined by workplace hygiene testing. Prolonged and
repeated exposure to airborne free respirable crystalline silica can result in lung disease (i.e., silicosis)
and/or lung cancer. The development of silicosis may increase the risks of additional health effects.
The risk of developing silicosis is dependent upon the exposure intensity and duration.
Eyes
None known.